Eylea and Vitreous floaters - from FDA reports


Summary

Vitreous floaters is found among people who take Eylea, especially for people who are female, 60+ old , have been taking the drug for < 1 month, also take medication Avastin, and have Age-related macular degeneration. This review analyzes which people have Vitreous floaters with Eylea. It is created by eHealthMe based on reports of 6,671 people who have side effects when taking Eylea from FDA, and is updated regularly.

What to expect?

If you take Eylea and have Vitreous floaters, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Eylea and have Vitreous floaters

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Jul, 26, 2017

6,671 people reported to have side effects when taking Eylea.
Among them, 146 people (2.19%) have Vitreous floaters


Number of reports submitted per year:

Could Eylea cause Vitreous floaters?

Time on Eylea when people have Vitreous floaters *:

  • < 1 month: 67.5 %
  • 1 - 6 months: 12.5 %
  • 6 - 12 months: 2.5 %
  • 1 - 2 years: 12.5 %
  • 2 - 5 years: 5.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Vitreous floaters when taking Eylea *:

  • female: 63.29 %
  • male: 36.71 %

Age of people who have Vitreous floaters when taking Eylea *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 3.57 %
  • 50-59: 1.79 %
  • 60+: 94.64 %

Top conditions involved for these people *:

  • Age-Related Macular Degeneration (52 people, 35.62%)
  • Diabetic Retinal Oedema (5 people, 3.42%)
  • Retinal Vessel Occlusion (4 people, 2.74%)
  • Macular Oedema (4 people, 2.74%)
  • Diabetic Retinopathy (2 people, 1.37%)

Top co-used drugs for these people *:

  • Avastin (8 people, 5.48%)
  • Lucentis (6 people, 4.11%)
  • Metformin (4 people, 2.74%)
  • Coumadin (4 people, 2.74%)
  • Betadine (4 people, 2.74%)

Top other side effects for these people *:

  • Vision Blurred (33 people, 22.60%)
  • Visual Acuity Reduced (32 people, 21.92%)
  • Visual Impairment (28 people, 19.18%)
  • Eye Pain (26 people, 17.81%)
  • Blindness (21 people, 14.38%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Vitreous floaters when taking Eylea?

Expand the study to include all drugs with the same ingredients

Vitreous floaters and drugs with ingredients of aflibercept.

Eylea

Eylea has active ingredients of aflibercept. It is often used in macular degeneration. (latest outcomes from Eylea 5,438 users)

Vitreous floaters

Vitreous floaters (spots before the eyes) has been reported by people with multiple sclerosis, high blood pressure, rheumatoid arthritis, osteoporosis, age-related macular degeneration (latest reports from 4,629 Vitreous floaters patients).

Browse all side effects of Eylea

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Vitreous floaters

Vitreous floaters

Could your condition cause Vitreous floaters

Vitreous floaters

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Eylea and have Vitreous floaters.

You may be interested in these reviews

More reviews for: Eylea, Vitreous floaters